Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01978288 · ClinicalTrials.gov registry record
Upper Airway Microbial Development During the First Year of Life
A clinical trial of Asthma, sponsored by Indiana University.
- Active
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT01978288 is a study of Asthma that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 180 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01978288, a study of Asthma, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the hypothesis that an increase in pathogenic bacteria within the infant airway leads to increased airway inflammation, decreased airway function and ultimately airway obstruction throughout the first one to two years of life.
Conditions Studied
Study Locations (1)
Indiana
- Riley Hospital for Children at Indiana University Health - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2014-01 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01978288
The ClinicalTrials.gov registry entry for NCT01978288 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (88% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT01978288 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT01978288 about?
NCT01978288 is a clinical study titled "Upper Airway Microbial Development During the First Year of Life". This study tests the hypothesis that an increase in pathogenic bacteria within the infant airway leads to increased airway inflammation, decreased airway function and ultimately airway obstruction throughout the first one to two years of life.
What is the current status of trial NCT01978288?
This trial is currently active not recruiting. The enrollment target is 180 participants. The study started on 2014-01. Estimated completion is 2025-12-31.
What conditions does trial NCT01978288 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT01978288?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01978288 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.